Credit rating
Company information
21Manufacture of basic pharmaceutical products and pharmaceutical preparations
About the company
H. LUNDBECK A/S (CVR number: 56759913K) is a company from KØBENHAVN. The company reported a net sales of 19912 mDKK in 2023, demonstrating a growth of 9.1 % compared to the previous year. The operating profit percentage was at 16 % (EBIT: 3195 mDKK), while net earnings were 2290 mDKK. The profitability of the company measured by Return on Assets (ROA) was 8.8 %, which can be considered good and Return on Equity (ROE) was 10.7 %, which can be considered good. The equity ratio, a key indicator for solidity, stood at 58.9 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. H. LUNDBECK A/S's liquidity measured by quick ratio was 1.1 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.
Financial information
See financialsNet sales (mDKK)
EBIT (mDKK)
Profitability
Solidity
Key figures (mDKK)
See financials| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Volume | |||||
| Net sales | 17 036.00 | 17 672.00 | 16 299.00 | 18 246.00 | 19 912.00 |
| Gross profit | 13 196.00 | 13 506.00 | 12 651.00 | 14 295.00 | 15 427.00 |
| EBIT | 3 153.00 | 1 990.00 | 2 010.00 | 2 852.00 | 3 195.00 |
| Net earnings | 2 313.00 | 1 581.00 | 1 318.00 | 1 916.00 | 2 290.00 |
| Shareholders equity total | 16 782.00 | 16 973.00 | 18 279.00 | 20 779.00 | 22 045.00 |
| Balance sheet total (assets) | 38 133.00 | 36 029.00 | 34 653.00 | 37 452.00 | 37 407.00 |
| Net debt | 6 349.00 | 3 761.00 | 2 792.00 | 1 761.00 | -1 080.00 |
| Profitability | |||||
| EBIT-% | 18.5 % | 11.3 % | 12.3 % | 15.6 % | 16.0 % |
| ROA | 10.6 % | 6.1 % | 5.7 % | 8.3 % | 8.8 % |
| ROE | 14.9 % | 9.4 % | 7.5 % | 9.8 % | 10.7 % |
| ROI | 14.5 % | 7.8 % | 7.5 % | 11.0 % | 11.8 % |
| Economic value added (EVA) | 2 064.96 | 644.22 | 760.23 | 1 200.18 | 1 402.72 |
| Solvency | |||||
| Equity ratio | 44.0 % | 47.1 % | 52.7 % | 55.5 % | 58.9 % |
| Gearing | 55.8 % | 45.3 % | 27.7 % | 25.5 % | 17.8 % |
| Relative net indebtedness % | 107.7 % | 85.6 % | 86.5 % | 71.9 % | 52.0 % |
| Liquidity | |||||
| Quick ratio | 0.7 | 0.8 | 0.6 | 0.9 | 1.1 |
| Current ratio | 0.9 | 1.0 | 1.0 | 1.4 | 1.7 |
| Cash and cash equivalents | 3 008.00 | 3 924.00 | 2 279.00 | 3 548.00 | 5 010.00 |
| Capital use efficiency | |||||
| Trade debtors turnover (days) | 59.3 | 52.7 | 55.1 | 54.2 | 54.4 |
| Net working capital % | -7.3 % | 0.5 % | -1.3 % | 17.6 % | 26.6 % |
| Credit risk | |||||
| Credit rating | A | A | A | AA | AA |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.